Intuitive Surgical Inc. ($ISRG) Stock Forecast: Down 5.1% Today

What is Intuitive Surgical Inc.?

Intuitive Surgical, Inc. (ISRG) Bearish Movement Intuitive Surgical, Inc. (ISRG) is a leading medical equipment provider renowned for its innovative robotic surgical systems, particularly the da Vinci Surgical System, with a strong focus on enhancing surgical outcomes through technology integration.

Why is Intuitive Surgical Inc. going down?

ISRG stock is down 5.1% on Feb 4, 2026 14:46

• Machina Capital S.A.S. and other significant institutional investors have notably increased their holdings in ISRG, signaling confidence in the company's future.
• Despite positive Q3 performance and strategic growth positioning, ISRG witnessed a bearish movement, potentially attributed to profit-taking or shifts in market sentiment.
• The upcoming earnings release from Zimmer Biomet Holdings (ZBH) might have impacted market dynamics, leading to a more cautious approach towards medical equipment stocks like ISRG.
• Market sentiments surrounding healthcare and medical technology sectors likely influenced ISRG's bearish movement, despite its favorable long-term growth prospects.

ISRG Price Chart

ISRG Technical Analysis

ISRG News

Machina Capital S.A.S. Buys 10,751 Shares of Intuitive Surgical, Inc. $ISRG

Machina Capital S.A.S. significantly increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 279.7% in the third quarter, purchasing an additional 10,751 shares. This makes Intuitive Surgical the 7th largest position in Machina Capital S.A.S.'s portfolio, with holdings valued at $6.53 million. Other major institutional investors like Vanguard Group, State Street Corp, and Geode Capital Management also increased their positions in the medical equipment provider.

https://www.marketbeat.com/instant-alerts/filing-machina-capital-sas-buys-10751-shares-of-intuitive-surgical-inc-isrg-2026-02-04/

Intuitive Surgical, Inc. (ISRG): A Bull Case Theory

This article summarizes a bullish thesis on Intuitive Surgical, Inc. (ISRG), highlighting its strong Q3 2025 results driven by the successful launch of the da Vinci 5 system and accelerated procedure volumes. The company's strategic focus on an integrated ecosystem and recurring revenue from instruments and accessories positions it for sustained growth. Despite competition and hospital spending risks, its technological leadership and growing installed base suggest a new "golden growth phase" for long-term investors.

https://finviz.com/news/298632/intuitive-surgical-inc-isrg-a-bull-case-theory

3 Reasons ZBH is Risky and 1 Stock to Buy Instead

This article evaluates Zimmer Biomet Holdings (ZBH), cautioning investors due to disappointing long-term revenue growth, a dropping free cash flow margin, and unimpressive past growth initiatives. Despite a reasonable forward P/E, the analysis suggests superior investment opportunities exist. The authors recommend looking into high-quality industrial businesses or other high-growth stocks.

https://finviz.com/news/296708/3-reasons-zbh-is-risky-and-1-stock-to-buy-instead

Reasons to Add Cooper Companies Stock to Your Portfolio Now

The Cooper Companies (COO) is positioned for growth due to strong performance in its CooperVision segment, particularly with its MyDay premium lens portfolio, and advancements in CooperSurgical's women's health and fertility offerings. While the company anticipates meaningful margin and free cash flow expansion, it faces challenges from gross margin pressures related to product mix and tariffs, as well as weakness in the Asia-Pacific market and uncertainty in the fertility sector. Despite these headwinds, the company's aggressive shareholder returns, disciplined capital allocation strategy, and positive long-term growth estimates make it an attractive investment.

https://sg.finance.yahoo.com/news/reasons-add-cooper-companies-stock-181700882.html

Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zimmer Biomet (ZBH) is anticipated to report a year-over-year increase in earnings and higher revenues for the quarter ending December 2025, with results expected on February 10. While the consensus estimate shows earnings growth, recent analyst revisions have slightly lowered the EPS outlook. The stock currently holds a Zacks Rank #3, but its negative Earnings ESP of -0.40% suggests it may not be a strong candidate for an earnings beat despite a strong past performance of exceeding EPS estimates four times in the last four quarters.

https://finviz.com/news/297665/zimmer-biomet-zbh-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release

Trending Today

XRP ($XRP) Crypto Forecast: Down 12.8% Today

Ethereum ($ETH) Crypto Forecast: Down 10.3% Today

Silver ($XAG) Commodity Forecast: Down 6.2% Today

Jupiter ($JUP) Crypto Forecast: Down 17.9% Today

ZCash ($ZEC) Crypto Forecast: Down 16.5% Today

Monero ($XMR) Crypto Forecast: Down 20.5% Today

Bitcoin ($BTC) Crypto Forecast: Down 9.5% Today

Copper ($COPPER) Commodity Forecast: Down 5.2% Today

TRON ($TRX) Crypto Forecast: Down 5.1% Today

Gold ($XAU) Commodity Forecast: Down 5.1% Today

Intuitive Surgical Inc. Price History

23.03.2025 - ISRG Stock was up 7.0%

• Intuitive Surgical reported impressive Q1 earnings and revenue, beating analyst estimates, which likely contributed to the bullish market movement.
• Despite concerns about profit margin impact from tariffs, the company's solid financial performance and optimistic outlook buoyed investor confidence.
• Analysts remain bullish on ISRG, providing support for the stock even amidst technical bearish trends.
• The anticipation of strong performance in the Instruments & Accessories segment further fueled optimism among investors, driving the stock's upward trajectory.

09.05.2025 - ISRG Stock was up 2.5%

• ISRG's shares have been on a recovery path, gaining 12.7% quarter-to-date after a significant decline from its all-time high. Investors are now eyeing the stock for a potential buying opportunity.
• The company's latest innovation, the da Vinci 5 surgical system, is garnering attention for its precision, power, and potential, with strong placements in Q1 driving adoption rates.
• ISRG outpaced the stock market gains, closing the day with a 1.11% increase, showcasing resilience and investor confidence in the company's future prospects.
• The options market sentiment towards ISRG is notably bullish, indicating a positive outlook from deep-pocketed investors. This optimism could be contributing to the stock's upward momentum as market players take note of this significant move.

04.01.2026 - ISRG Stock was down 5.1%

• Machina Capital S.A.S. and other significant institutional investors have notably increased their holdings in ISRG, signaling confidence in the company's future.
• Despite positive Q3 performance and strategic growth positioning, ISRG witnessed a bearish movement, potentially attributed to profit-taking or shifts in market sentiment.
• The upcoming earnings release from Zimmer Biomet Holdings (ZBH) might have impacted market dynamics, leading to a more cautious approach towards medical equipment stocks like ISRG.
• Market sentiments surrounding healthcare and medical technology sectors likely influenced ISRG's bearish movement, despite its favorable long-term growth prospects.

10.11.2025 - ISRG Stock was down 2.8%

• An institutional investor increased its stake in ISRG by 1.2% in Q2, despite recent insider selling by executives, following the company's strong Q3 earnings.
• Another institutional investor, Daiwa Securities Group Inc., sold 6,055 shares of ISRG, reducing its holdings, while other institutional investors also adjusted their positions in the company.
• The market movement could be attributed to profit-taking by institutional investors after a period of significant growth, despite positive earnings and analyst consensus ratings.
• The bearish trend might also be influenced by overall market conditions and investor sentiment towards the healthcare sector, as highlighted by the positive performance of other surgical equipment companies in Q3.

06.00.2026 - ISRG Stock was up 3.7%

• Despite significant insider selling and reduced stakes by asset management firms, major institutional investors increasing their positions in ISRG have likely instilled confidence in the market.
• The utilization of AI in driving growth and innovation within the medical sector has positioned companies like Intuitive Surgical for strong performance, attracting investors and contributing to the bullish movement.
• While the stock may be trading at a premium valuation with a high P/E ratio, the perceived undervaluation and potential for future growth due to product innovation and AI integration have likely fueled investor optimism, leading to the bullish market movement.

06.00.2026 - ISRG Stock was up 5.0%

• Noteworthy insider selling by Greenleaf Trust and Hennion & Walsh Asset Management Inc. did not deter overall market optimism towards ISRG today.
• Discussions around the utilization of Artificial Intelligence (AI) in the medical sector, including within companies like ISRG, likely influenced investor sentiment positively, reflecting interest in the company's growth prospects.
• ISRG's strong earnings report, surpassing revenue and EPS projections, is seen as a key factor reinforcing investor trust in the company's future performance.
• Variations in institutional investors' behavior, with some increasing stakes and others decreasing positions in ISRG, suggest diverse views on the company's long-term outlook. Nevertheless, the prevailing market sentiment remained favorable, supporting the bullish trend in ISRG.

14.00.2026 - ISRG Stock was down 5.5%

• Despite strong Q4 revenue and procedure growth, ISRG's stock saw a 6% decline in pre-market trading.
• Concerns regarding a slowdown in Ion endoluminal system placements, despite an increase in da Vinci system placements, appear to have fueled the bearish movement.
• Investor sentiment may have been influenced by the company's anticipation of a potential deceleration in da Vinci procedures growth for 2026.
• Watching for the stock's current undervaluation in comparison to estimated fair value, as well as expected advancements in AI-enabled surgery, could be crucial for potential future market movements.

02.00.2026 - ISRG Stock was down 1.2%

• The downturn in ISRG stock today may be linked to investors seizing profits following a recent rise in the stock price.
• Despite notable developments like a robust Q3 performance and increased interest from institutional investors, market sentiment could be swayed by overall uncertainty and volatility in the healthcare domain.
• The forthcoming Q4 earnings call set for January 22 might influence the stock's trajectory, as investors await insights on future growth prospects.
• The market's perception of ISRG could also be influenced by broader economic conditions and industry trends impacting healthcare and technology sectors.

22.09.2025 - ISRG Stock was up 16.5%

• ISRG exceeded Q3 earnings and revenue expectations, demonstrating robust financial performance.
• The introduction of the new da Vinci 5 system is stimulating hospital upgrades and premium pricing, potentially influencing the strong performance in Q3.
• Investors responded favorably to ISRG's solid Q3 results, resulting in a notable increase in the stock price.
• The company's consistent track record of impressive earnings and positive future prospects are likely driving the current bullish trend in ISRG's stock.

22.09.2025 - ISRG Stock was up 13.4%

• Third-quarter results revealed that Intuitive Surgical achieved $2.51 billion in revenue, a 23% increase from the previous year, surpassing predictions. The surge in da Vinci placements and global procedure growth fueled this remarkable performance.
• Despite a slight gross margin dip, the company's adjusted earnings of $2.40 per share exceeded forecasts, propelling ISRG stock by 17%.
• Investor optimism was evident as the market responded favorably to the earnings and revenue beat, showcasing confidence in Intuitive Surgical's financial prowess and industry prominence.
• With a track record of surpassing earnings estimates and a bright outlook, Intuitive Surgical is positioned to potentially surpass expectations in the future, contributing to the bullish trend in its stock value.

01.09.2025 - ISRG Stock was down 2.1%

• The bearish movement in ISRG stock may be linked to profit-taking by investors following a recent positive trend.
• Concerns over the national security review affecting the medical supply chain may have contributed to uncertainty in the healthcare sector, prompting a sell-off in ISRG shares.
• There might be worries among investors about potential disruptions in the supply chain of medical devices, including robotic surgery systems, which could impact ISRG's operations and revenue.
• The market's response to the national security review may have sparked a broader sell-off in healthcare stocks, including ISRG, as investors reevaluate the risks associated with the sector.

23.06.2025 - ISRG Stock was down 2.8%

• Despite exceeding Q2 earnings and revenue estimates, ISRG's stock took a bearish turn.
• Concerns rose among investors due to a decrease in gross margin outlook impacted by tariffs, overshadowing the positive earnings results.
• The FDA's approval for ISRG's Vessel Sealer Curved, adding to the da Vinci system's capabilities, may have been overshadowed by the margin outlook news.
• Comparisons with rival Stryker in the robotic surgery sector potentially affected investor sentiment, contributing to the bearish trend in ISRG's stock.